Kent is a seasoned life sciences R&D executive and current Consulting Director at BioIVT, with extensive experience in drug discovery, preclinical development, and operations. He holds a Ph. D. from Washington University in St. Louis and is recognized by colleagues for his insightful, hands-on, and science-driven perspective in advancing therapeutic programs from concept to IND-enabling status.
Based in Boise, Idaho, Kent is a key opinion leader in the application of New Approach Methodologies (NAMs) to replace, reduce, and refine animal use in drug development. He frequently speaks at industry events and contributes to publications on the topic, advocating for a coordinated approach to validate and standardize human-relevant alternatives.
He has an h-index of 15 and has been cited over 3, 400 times for his scientific publications.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.